RECOVERY Collaborative GroupCooper, Jamie2025-10-152023-12RECOVERY Collaborative Group & Cooper, J 2023, 'Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial', The lancet. Diabetes & endocrinology, vol. 11, no. 12, pp. 905-914. https://doi.org/10.1016/S2213-8587(23)00253-X2213-8587PubMedCentral: PMC10957483ORCID: /0000-0003-3812-7026/work/194700171https://hdl.handle.net/2164/26231Above all, we would like to thank the thousands of patients who participated in this trial. We would also like to thank the many doctors, nurses, pharmacists, other allied health professionals, and research administrators at NHS hospital organisations across the whole of the UK, supported by staff at the National Institute of Health Research (NIHR) Clinical Research Network, NHS DigiTrials, Public Health England, Department of Health and Social Care, the Intensive Care National Audit and Research Centre, Public Health Scotland, National Records Service of Scotland, the Secure Anonymised Information Linkage at University of Swansea, and the NHS in England, Scotland, Wales, and Northern Ireland.10798758engSDG 3 - Good Health and Well-beingAdultHumansCOVID-19SARS-CoV-2HospitalizationHospitalsTreatment OutcomeR Medicine (General)Supplementary DataDASLinkR1Journal article10.1016/S2213-8587(23)00253-X